Suchergebnisse - "Lodola, Alessio"

PubPharm (186)

1

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

enthalten in: Biochemical pharmacology | 2024

von Eltayeb, K. | Alfieri, R. | Fumarola, C. | +12

2

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

enthalten in: Scientific reports | 2024

von La Monica, S. | Vacondio, F. | Eltayeb, K. | +16

3

Drug discovery : In silico dry data can bypass biological wet data?

enthalten in: British journal of pharmacology | 2024

von Tognolini, M. | Lodola, A. | Giorgio, C.

4

Peptidyl Nitroalkene Inhibitors of Main Protease (Mpro) rationalized by Computational/Crystallographic Investigations as Antivirals against SARS-CoV-2

enthalten in: ResearchSquare.com | 2024

von Medrano, F. | Hoz-Rodríguez, S. | Martí, S. | +12

5

Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2

enthalten in: Communications chemistry | 2024

von Medrano, F. | de la Hoz-Rodríguez, S. | Martí, S. | +15

6

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity

enthalten in: Journal of chemical information and modeling | 2023

von Guidetti, L. | Zappia, A. | Scalvini, L. | +11

7

Discovery of SARS-CoV-2 M^proPeptide Inhibitors from Modelling Substrate and Ligand Binding

enthalten in: bioRxiv.org | 2023

von Chan, H. | Moesser, M. | Walters, R. | +24

8

A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer : UniPR1331 Efficacy Evidence

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Festuccia, C. | Corrado, M. | Rossetti, A. | +5

9

Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations

enthalten in: Journal of chemical information and modeling | 2023

von Galvani, F. | Pala, D. | Cuzzolin, A. | +4

10

Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists : A successful application of target hopping approach

enthalten in: Biochemical pharmacology | 2023

von Ferrari, F. | Giorgio, C. | Zappia, A. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]